References
- Bendich A., Getler H., Brown G., Koechlin B., et al. 1949; 1966
- Grunberg E., Prince H., Utz P. Observations on the activity of two newer anti-fungal agents: saramycetin (X-5079 C) and 5-fluorocytosine. Fifth International Congress Chemotherapy (Wien, 1967). Med. Akademie, Wien 1967; vol. 4: 69
- Hyun B., Collier F. Mycotic endocarditis following intracardiac operations. Report of four cases. New Engl J Med 1960; 263: 1339
- Jund R., Lacroute F. Genetic and physiological aspects of resistance to 5-Fluoropyrimidines in Saccharomyces cerevisiae. J Bact 1970; 102: 607
- Koechlin B., Rubio F., Palmer S., Gabriel T., Duschinsky R. The metabolism of 5-Fluorocytosine-214C and of cytosine-14C in the rat and the disposition of 5-Fluorocytosine-214C in man. Biochem Pharmacol 1966; 15: 435
- McGill P., Sequeira R., Jindani E., Nguli E., Forrester A., Fulton W. 5-Fluorocytosine in the treatment of cryptococcal meningitis. E Afr Med J 1969; 46: 1
- Scholer H. J. Seventh Wissenschaftlichen Tagung der Deutschsprachigen Mykologischen Gesellschaft. Krefeld 1969
- Scholer H. J. Antimykoticum 5-Fluorocytosin. Mykosen 1970; 13: 119
- Schönebeck J. Incidence of yeast-like fungi in gastric juice under normal and pathological conditions. Gastroenterology 1968; 3: 351
- Schönebeck J., Anderson L., Lingårdh G., Winblad B. Ureteric obstruction caused by yeast-like fungi. Scand J Urol Nephrol 1970; 4: 171
- Shadomy H., Shadomy J., McGay A., Utz J. In vivo susceptibility studies with Cryptococcus neoformans and Amphotericin B, Hamycin and 5-Fluorocytosine. Anti-microbial Agents and Chemotherapy. Amer Soc Microbiol, Ann Arbor 1968; 452, 1969
- Shadomy S. In vitro studies with 5-Fluorocytosine. Appl Microbiol 1969; 17: 871
- Winner H., Hurley R. Candida albicans. Churchill, London 1964